• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INNOVA; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INNOVA; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number 26921
Device Problem Premature Activation (1484)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/05/2024
Event Type  malfunction  
Event Description
It was reported that stent premature deployment occurred.The 80% stenosed, and 13-cm long target lesion was located in the middle part of the iliac artery.After crossing the lesion with a guidewire, balloon pre-dilation was performed.An 8 x 150 x 130 innova stent was selected for use; however, during unpacking, it was found that part of the stent had been deployed outside the protective sheath.The procedure was completed with another of same device.There were no complications reported and the patient was stable post procedure.
 
Manufacturer Narrative
The device was returned for evaluation.The outer sheath, tip, inner sheath and the remainder of the device were checked for damage.Visual examination revealed that the stent is partially deployed approximately 1cm from the middle sheath.There is a kink to the outer sheath at the nosecone and 3.7cm from the nosecone.Microscopic examination revealed no additional damages.The lock and pull rack are still in the manufactured location.No other issues were identified during the product analysis.
 
Event Description
It was reported that stent premature deployment occurred.The 80% stenosed, and 13-cm long target lesion was located in the middle part of the iliac artery.After crossing the lesion with a guidewire, balloon pre-dilation was performed.An 8 x 150 x 130 innova stent was selected for use; however, during unpacking, it was found that part of the stent had been deployed outside the protective sheath.The procedure was completed with another of same device.There were no complications reported and the patient was stable post procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INNOVA
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key19028765
MDR Text Key339221758
Report Number2124215-2024-16192
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/25/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number26921
Device Catalogue Number26921
Device Lot Number0031376474
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/01/2024
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/02/2024
Supplement Dates Manufacturer Received04/08/2024
Supplement Dates FDA Received04/25/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/05/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age82 YR
Patient SexMale
Patient Weight70 KG
-
-